Recombinant activated factor VII for acute intracerebral hemorrhage

Keyphrases

• Intracerebral Hemorrhage 100%
• Spontaneous Intracerebral Hemorrhage 100%
• Recombinant Activated Factor VII (rFVIIa) 100%
• Hemostasis 50%
• Relative Reduction 50%
• Hematoma Growth 50%
• Improved Outcomes 25%
• Poor Outcome 25%
• Myocardial Infarction 25%
• Survivors 25%
• Mortality Rate 25%
• Placebo-controlled 25%
• Ischemic Stroke 25%
• Bleeding 25%
• Functional Outcome 25%
• Randomized Double-blind 25%
• Proof of Concept Study 25%
• Recurrent Bleeding 25%
• Bleeding Outcomes 25%
• Phase II Trial 25%
• Dose-ranging 25%
• Hemorrhage Volume 25%
• Coagulation 25%
• Arterial Thromboembolic Events 25%
• Hematoma Volume 25%
• Hemophilia Patients 25%
• Stroke Treatment 25%
• Acute Hemorrhagic Stroke 25%
• Volume Growth 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Hemorrhage 100%
• Blood Clotting Factor 7 100%
• Hematoma 50%
• Bleeding 33%
• Blood Stasis 33%
• Heart Infarction 16%
• Mortality Rate 16%
• Placebo 16%
• Brain Ischemia 16%
• Thromboembolism 16%
• Cerebrovascular Accident 16%
• Haemophilia A 16%

Medicine and Dentistry

• Factor VII 100%
• Cerebral Hemorrhage 100%
• Hematoma 50%
• Bleeding 33%
• Blood Stasis 33%
• Apoplexy 16%
• Myocardial Infarction 16%
• Placebo 16%
• Thromboembolism 16%
• Mortality Rate 16%
• Brain Ischemia 16%
• Patient with Hemophilia 16%